Brown, Lisle/Cummings, Inc. Ark Genomic Revolution ETF (De Transaction History
Brown, Lisle/Cummings, Inc.
- $390 Billion
- Q3 2025
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 325 shares of ARKG stock, worth $8,739. This represents 0.0% of its overall portfolio holdings.
Number of Shares
325
Previous 325
-0.0%
Holding current value
$8,739
Previous $7.91 Million
14.04%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ARKG
# of Institutions
297Shares Held
20.3MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio